비교효과평가를 위한 성과연구 = Comparative Effectiveness Evaluation as Outcomes Research

다국어 초록 (Multilingual Abstract)

In spite of being several results of efficacy obtained by randomized controlled trials about new health technologies, evidences related to real effectiveness confirmed by head-to-head direct comparison should be needed in order to improve qualities of healthcare. The comparative effectiveness evaluation (CEE) as outcomes research have suggested as the important tool for developing evidence-based information to patients, clinicians, and other decision makers about which technologies are most effective for which patients under specific circumstances. Four major methods of outcomes research are applied as systematic reviews and meta-analyses, cohort studies using registries, linkage of large databases, and pragmatic clinical trials. Through activating the CEE, the best and most effective technologies should be adopted rapidly in routine clinical practices.

참고문헌 (Reference)

1 Caper P, "Variations in medical practice : implications for health policy" 3 : 110-119, 1984

2 Curtis JR, "Training pulmonary and critical care physicians in outcomes research: should we take the challenge?" 157 (157): 1012-1015, 1998

3 Dougherty D, "The"3T's"road map to transform US health care : the"how"of high-quality care" 299 : 2319-2321, 2008

4 Hampton JR, "The use of beta blockers following myocardial infarction-doubts" 4 : 151-157, 1983

5 Pratt CM, "The role of beta-blockers in the treatment of patients after infarction" 2 : 13-20, 1984

6 Hotopf M, "The pragmatic randomised controlled trial" 8 : 326-333, 2002

7 Pedersen TR, "The Norwegian Multicenter Study of Timolol after Myocardial Infarction" 67 (67): 49-53, 1983

8 ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group., "The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)" 288 : 2981-2997, 2002

9 Salive ME, "Patient Outcomes Research Teams and the Agency for Health Care Policy and Research" 25 : 697-708, 1990

10 Gilbody SM, "Outcomes research in mental health : systematic review" 181 : 8-16, 2002

11 Bruner DW, "Outcomes research in cancer symptom management trials: the Radiation Therapy Oncology Group (RTOG) conceptual model" 37 : 12-15, 2007

12 Institute of Medicine, "Initial national priorities for comparative effectiveness research. Washington" The National Academies Press 13-, 2009

13 Brook RH, "Geographic variations in the use of services: do they have any clinical significance?" 3 : 63-73, 1984

14 Manchikanti L, "Facts, fallacies, and politics of comparative effectiveness research: Part I. basic considerations" 13 : 23-54, 2010

15 Spertus JA, "Expanding the outcomes in clinical trials of heart failure : the quality of life and economic components of EPHESUS(EPlerenone's neuroHormonal Efficacy and SUrvival Study)" 143 : 636-642, 2002

16 Lee TH, "Eulogy for a quality measure" 357 : 1175-1177, 2007

17 Reynolds JL, "Effects of a beta-adrenergic receptor blocker in myocardial infarction treated for one year from onset" 34 : 252-259, 1972

18 Roberts I, "Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury(MRC CRASH trial) : randomised placebo-controlled trial" 364 : 1321-1328, 2004

19 Roland JM, "Effect of beta-blockers on arrhythmias during six weeks after suspected myocardial infarction" 2 : 518-521, 1979

20 Wennberg JE, "Dealing with medical practice variations : a proposal for action" 3 : 6-32, 1984

21 Vogenberg FR, "Comparative effectiveness research: valuable insight or government intrusion?" 34 : 684-685, 2009

22 Pratt CM, "Chronic beta blockade therapy in patients after myocardial infarction" 52 : 661-664, 1983

23 Baber NS, "Beta-adrenoceptor blockade and myocardial infarction: when should treatment start and for how long should it continue?" 67 (67): 71-77, 1983

24 Karanicolas PJ, "A new 'mechanistic-practical’' framework for designing and interpreting randomized trials" 62 : 479-484, 2009

25 Antman EM, "A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts : treatments for myocardial infarction" 268 : 240-248, 1992